Synergy CHC Has UrgentRx Ticket To Enter OTC Market
This article was originally published in The Tan Sheet
Executive Summary
Synergy also acquires Australian brand Flat Tummy Tea. Both deals partly are financed through a $5.5m loan from Knight Therapeutics, a Canadian firm that in January also provided Synergy with a $6m loan to acquire the Focusfactor dietary supplement brand.
You may also be interested in...
Interview: Fugate Attracted By UrgentRx Focus On Branding, Unique Positioning
Ron Fugate sees UrgentRx not only using some of the strongest marketing strategies he’s known for building a successful consumer health care product brand, but also making headway in new areas important to driving sales for new products.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.